Novel antimicrobial biomaterials, grounded in regional biodiversity.
Our programmes span discovery science, formulation development, and pilot-scale evaluation — each pathway designed to end in a licensable technology or product.
Plant-derived antimicrobials
Screening and characterisation of bioactive compounds from Southeast Asian medicinal plants against resistant pathogens.
Biomaterial formulations
Hydrogels, films, coatings, and nanocarriers engineered to deliver natural actives with stability and shelf life.
Anti-biofilm strategies
Novel approaches targeting the biofilms responsible for chronic wounds, medical-device infections, and crop disease.
Preclinical evaluation
In vitro and in vivo efficacy and safety testing to prepare technologies for regulatory and industry handoff.
Publications
Our team publishes in Journal of Ethnopharmacology, Antibiotics, Journal of Applied Microbiology, and other peer-reviewed venues. A full publication list is available on request.